Who owns ZENAS BIOPHARMA INC?
- Ticker: ZBIO
- CUSIP Number: 98937l105
Tip: Access positions for across all investors
Analyze quarterly positions in Zenas Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Zenas Biopharma stock
Who bought or sold ZENAS BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sr One Capital Management | 4.9M | $109M | 0% | Sep 2025 |
|
| FMR | 4.8M | $107M | 45% | Sep 2025 |
|
| Enavate Sciences GP | 3.8M | $84M | 0% | Sep 2025 |
|
| NEA Management Company | 2.7M | $61M | 0% | Sep 2025 |
|
| Novo A/S | 2.0M | $44M | -11% | Sep 2025 |
|
| Fairmount Funds Management | 1.9M | $42M | 0% | Sep 2025 |
|
| Federated Investors | 1.9M | $41M | 0% | Sep 2025 |
|
| NVP Associates | 1.8M | $41M | 0% | Sep 2025 |
|
| Deerfield Management Company | 1.6M | $35M | 0% | Sep 2025 |
|
| BlackRock | 1.2M | $27M | 12% | Sep 2025 |
|
| Vivo Capital | 1.2M | $26M | 0% | Sep 2025 |
|
| Vanguard Group | 1.2M | $26M | 17% | Sep 2025 |
|
| Wellington Management Company | 858k | $19M | -2% | Sep 2025 |
|
| Arrowpoint Asset Management | 825k | $18M | -25% | Sep 2025 |
|
| Pivotal bioVenture Partners Investment Advisor | 779k | $17M | 0% | Sep 2025 |
|
| Rock Springs Capital Management | 581k | $13M | -9% | Sep 2025 |
|
| Geode Capital Management | 470k | $10M | 26% | Sep 2025 |
|
| State Street Corporation | 378k | $8.4M | 22% | Sep 2025 |
|
| Charles Schwab Investment Management | 178k | $4.0M | 46% | Sep 2025 |
|
| Eversept Partners | 159k | $3.5M | -51% | Sep 2025 |
|
| Sectoral Asset Management | 152k | $3.4M | -28% | Sep 2025 |
|
| Invesco | 146k | $3.2M | 100% | Sep 2025 |
|
| Northern Trust | 133k | $3.0M | 12% | Sep 2025 |
|
| Morgan Stanley | 124k | $1.2M | 100% | Jun 2025 |
|
| Schroder Investment Management Group | 113k | $2.3M | -27% | Sep 2025 |
|
| Superstring Capital Management | 97k | $2.1M | -13% | Sep 2025 |
|
| Millennium Management | 72k | $1.6M | 100% | Sep 2025 |
|
| Bank of New York Mellon | 42k | $926k | 8% | Sep 2025 |
|
| Stempoint Capital | 39k | $860k | 100% | Sep 2025 |
|
| UBS Group | 36k | $788k | 46% | Sep 2025 |
|
| AQR Capital Management | 25k | $545k | 0% | Sep 2025 |
|
| Barclays | 23k | $508k | -18% | Sep 2025 |
|
| Rhumbline Advisers | 21k | $471k | 8% | Sep 2025 |
|
| Nuveen | 21k | $456k | -35% | Sep 2025 |
|
| Two Sigma Investments | 20k | $453k | 4% | Sep 2025 |
|
| ALPS Advisors | 20k | $445k | -11% | Sep 2025 |
|
| Alliancebernstein | 18k | $407k | 12% | Sep 2025 |
|
| Birchview Capital | 17k | $366k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 13k | $277k | 19% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 12k | $271k | 4267% | Sep 2025 |
|
| Creative Planning | 12k | $264k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 12k | $307k | 791% | Sep 2025 |
|
| American Century Companies | 11k | $244k | 100% | Sep 2025 |
|
| MetLife Investment Advisors | 10k | $224k | 0% | Sep 2025 |
|
| Susquehanna International | 10k | $224k | -48% | Sep 2025 |
|
| Mirae Asset Global Etfs Holdings | 7.5k | $166k | -16% | Sep 2025 |
|
| Jpmorgan Chase & Co | 6.5k | $145k | -10% | Sep 2025 |
|
| New York State Common Retirement Fund | 6.2k | $138k | 0% | Sep 2025 |
|
| Pnc Financial Services | 5.8k | $130k | -36% | Sep 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 4.5k | $100k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 3.1k | $70k | 120% | Sep 2025 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.8k | $62k | 0% | Sep 2025 |
|
| Summit Investment Advisors | 1.6k | $36k | 0% | Sep 2025 |
|
| CWM | 1.5k | $33k | 0% | Sep 2025 |
|
| Tower Research Capital | 1.4k | $31k | -45% | Sep 2025 |
|
| Legal & General Group | 1.4k | $30k | -13% | Sep 2025 |
|
| Russell Investments | 1.3k | $30k | 100% | Sep 2025 |
|
| California State Teachers Retirement System | 1.1k | $25k | 0% | Sep 2025 |
|
| Quarry | 1.1k | $25k | 35% | Sep 2025 |
|
| Sterling Capital Management | 1.1k | $25k | 155% | Sep 2025 |
|
| Us Bancorp | 953.00 | $21k | -10% | Sep 2025 |
|
| Amalgamated Bank | 524.00 | $12k | 0% | Sep 2025 |
|
| Aster Capital Management | 339.00 | $7.5k | 100% | Sep 2025 |
|
| Signature | 332.00 | $7.4k | 13% | Sep 2025 |
|
| GAMMA Investing | 183.00 | $4.1k | 132% | Sep 2025 |
|
| NISA Investment Advisors | 115.00 | $2.6k | 0% | Sep 2025 |
|
| SRS Capital Advisors | 115.00 | $2.6k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 104.00 | $2.3k | 100% | Sep 2025 |
|
| UMA Financial Services | 67.00 | $1.5k | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 58.00 | $1.3k | 0% | Sep 2025 |
|
| Farther Finance Advisors | 24.00 | $532.999200 | 100% | Sep 2025 |
|
| Hartland & Co | 23.00 | $511.000200 | 0% | Sep 2025 |
|
| Global Retirement Partners | 15.00 | $333.000000 | 100% | Sep 2025 |
|
| Sunbelt Securities | 11.00 | $243.999800 | 100% | Sep 2025 |
|
| True Wealth Design | 3.00 | $66.999900 | 0% | Sep 2025 |
|
| SBI Securities | 1.00 | $22.000000 | 100% | Sep 2025 |
|
Who sold out of Zenas Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 294k | $2.8M |
| Goldman Sachs Group | Mar 2025 | 24k | $189k |
| Ubs Global Asset Management Americas | Jun 2025 | 15k | $144k |
| Intech Investment Management | Jun 2025 | 13k | $128k |
| Alpine Partners VI | Jun 2025 | 13k | $125k |
| Sei Investments | Jun 2025 | 12k | $117k |